Skip to content

    Manorama Industries Limited

    MANORAMA
    Fast Moving Consumer Goods·28 Jan 2026
    Management Summary

    Manorama Industries reported strong Q3 and 9M FY26 results, driven by significant revenue growth and stable EBITDA margins. The company revised its FY26 revenue guidance upwards and announced a substantial INR 460 crores capex plan to expand capacity and introduce new value-added products. Management emphasized its technology-driven business model, which insulates it from commodity price volatility and ensures sustainable growth.

    Highlights

    5
    • Strong revenue growth of 81.3% YoY for 9M FY26, reaching INR 975 crores.

    • Robust EBITDA margin of 27.2% for 9M FY26 and 27.1% for Q3 FY26, demonstrating operational efficiency.

    • Upward revision of FY26 revenue guidance from INR 1,150 crores to INR 1,300 crores, reflecting confidence in growth trajectory.

    • Strategic INR 460 crores capex plan over 2-3 years to significantly expand capacity in high-growth product categories like CBA and fractionation.

    • Improved working capital cycle for new projects, expected to be 1-3 months compared to the existing 120 days.

    Concerns

    1
    • Gross margin fluctuation due to freight costs and byproduct realization, though management states it remains range-bound (45-50%) and does not impact EBITDA/PAT margins.

    Key financials

    Metrics

    12

    Periods

    3

    Headline

    1
    • Value-added product contribution to sales
      75%

    Q3 FY26

    5
    • Revenue
      ₹363 Cr
    • EBITDA
      ₹98 Cr
    • EBITDA Margin
      27.1%
    • PAT
      ₹68 Cr
    • PAT Margin
      18.8%

    9M

    6
    • FY26 Revenue
      ₹975 Cr
      YoY+81.3%
    • FY26 EBITDA
      ₹265 Cr
    • FY26 EBITDA Margin
      27.2%
    • FY26 PAT
      ₹174 Cr
    • FY26 PAT Margin
      17.8%

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    ₹460 crores

    entirely through internal accruals

    Guidance & targets

    10
    CategoryTargetPriority
    Revenue
    FY26 Revenue
    INR 1,300 crores
    High
    Capacity
    Existing Capacity Expansion
    30% increase (to 52,000 MTPA)
    High
    Capex
    Total Capex for New Projects
    INR 460 crores
    High
    Asset Turnover
    Asset Turnover for Forward Integration Projects
    >5x
    High
    Working Capital Cycle
    Working Capital Cycle for New Projects
    1-3 months
    High
    Working Capital Cycle
    Overall Working Capital Cycle
    90-100 days
    Medium
    Value-Added Products
    Value-Added Product Contribution to Sales
    85-90%
    Medium
    Profitability
    EBITDA Margin
    25-27%
    High
    Volume
    Mexico Plant Volume
    >2,000 tons
    Medium
    Revenue Growth
    FY27 Revenue Growth
    40-45%
    Medium

    Capex spend for FY26

    Next quarter
    CurrentINR 50-odd crores invested, INR 70-80 crores planned for FY26
    TargetProgress towards INR 70-80 crores for FY26

    Why it matters

    Tracking the execution of the announced INR 460 crores capex plan is crucial for future growth and capacity expansion.

    We plan to invest approximately INR 70 to 80 crores in this financial year to build capex.

    How to verify

    capital_allocation.capex.fy_planned

    Risks & concerns

    3
    RiskSeverity

    Gross margin fluctuation

    Gross margins can fluctuate due to freight costs and byproduct realization, as seen in Q3 FY26 (44.3% vs 52.8% last quarter), though management states it remains range-bound (45-50%) and does not impact EBITDA/PAT margins.Analyst acknowledged

    medium

    Cocoa price volatility

    Cocoa prices are volatile, but Manorama's products are not directly related to cocoa butter prices due to specialized fat blending and R&D, making the business less susceptible to commodity price swings.Analyst downplayed

    low

    EU deforestation rules

    EU deforestation rules, postponed until December 2026, primarily relate to cocoa beans and do not impact Manorama's sourcing of forest wasted products from India and West Africa, ensuring business continuity.Analyst not addressed

    low

    Q&A highlights

    8

    “ESOS is a process where we are going to convert our soft fractions like Olein and other soft oils into a hard fraction, which is called ESOS, enzymatic stearin-oleic-stearic. That will be further be used as a different application in the food sector and will be further blended with HPMF, which is called hard palm mid fraction, and it will become a CBE component thereafter, which has a wider application and usage in the food industry.”

    Explains the core technology and product strategy behind a significant portion of the new capex, detailing the value-added nature of the products.

    asked by Jeevan P.

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Q3 & 9M FY26 Financial Performance

    Manorama Industries reported robust financial results for Q3 and 9M FY26. For the nine-month period, revenue grew by an impressive 81.3% year-on-year to INR 975 crores, with an EBITDA of INR 265 crores, yielding a 27.2% margin. Profit after tax stood at INR 174 crores, representing a 17.8% margin. Q3 FY26 alone saw revenues of INR 363 crores and an EBITDA of INR 98 crores, with margins of 27.1% and 18.8% for EBITDA and PAT respectively.

    02

    Upward Revision of FY26 Revenue Guidance

    Buoyed by strong performance and confidence in its growth trajectory, the company revised its FY26 revenue guidance upwards. The new target is INR 1,300 crores, an increase from the previous guidance of INR 1,150 crores. This revision underscores the management's positive outlook on sustained demand and operational capabilities, including an enhanced mix of value-added products and optimized utilization of upgraded fractionation facilities.

    03

    Strategic INR 460 Crores Capex for Capacity Expansion

    Manorama Industries announced a significant capital expenditure plan of INR 460 crores over the next 2-3 years to fuel its next phase of growth. This investment will fund four key projects: a 75,000 MTPA facility for cocoa butter alternatives (CBA), a 75,000 MTPA fractionation plant for exotic seeds including ESOS, a 90,000 MTPA refinery, and a 90,000 MTPA processing factory in Burkina Faso, West Africa. These expansions are designed to meet growing demand and diversify the raw material base.

    04

    Focus on Value-Added Products and Margin Stability

    The company's strategy emphasizes a technology-driven, solution-oriented business model, distinct from commodity-linked operations. Management highlighted that its CBE fats and butters are developed through specialized fat blending and fractionation, leveraging advanced R&D. This approach, combined with strong customer relationships, allows for margin stability, with EBITDA margins consistently maintained in the 25-27% range, despite fluctuations in gross margins due to freight costs and byproduct realization. The company aims to increase value-added product contribution to sales from 75% to 85-90% going forward.

    05

    Improved Working Capital Management

    Manorama Industries expects a significant improvement in its working capital cycle with the new projects. While the existing business model has a working capital cycle of around 120 days (down from 150-160 days in H1), the new forward integration projects are projected to operate with a much shorter cycle of 1-3 months. This efficiency gain is attributed to the captive consumption of raw materials and different raw material sourcing for these new product lines, further strengthening the company's financial health.

    06

    Resilience Against External Factors

    Management addressed concerns regarding external factors such as cocoa price volatility and EU deforestation rules. They clarified that their business is not directly tied to cocoa commodity cycles due to their specialized product nature and diverse raw material base. Furthermore, the EU deforestation rules, which primarily apply to cocoa beans, do not impact Manorama's sourcing of forest wasted products from India and West Africa, ensuring business continuity and mitigating regulatory risks.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.